Zerviate (cetirizine ophthalmic) is filed as Ophthalmic Antihistamine. The sections below restate public label fields stored for this profile.
1 INDICATIONS AND USAGE ZERVIATE ® (cetirizine ophthalmic solution) 0.24% is indicated for the treatment of ocular itching associated with allergic conjunctivitis. ZERVIATE ® (cetirizine ophthalmic solution) 0.24% is a histamine-1 (H1) receptor antagonist indicated for treatment of ocular itching associated with allergic conjunctivitis. ( 1 )
12.1 Mechanism of Action ZERVIATE ® , an antihistamine, is a histamine-1 (H1) receptor antagonist. Its effects are mediated via selective inhibition of H1 histamine receptors. The antihistaminic activity of cetirizine has been documented in a variety of animal and human models. In vivo and ex vivo animal models have shown negligible anticholinergic and antiserotonergic activity. In vitro receptor binding studies have shown no measurable affinity for other than H1 receptors.
if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
4 CONTRAINDICATIONS None. None. ( 4 )
2 DOSAGE AND ADMINISTRATION The recommended dosage of ZERVIATE ® is to instill one drop in each affected eye twice daily (approximately 8 hours apart). The single-use containers are to be used immediately after opening and can be used to dose both eyes. Discard the single-use container and any remaining contents after administration. The single-use containers should be stored in the original foil pouch until ready to use. The recommended dose is one drop in each affected eye twice daily. ( 2 )
According to its FDA label, Zerviate (cetirizine ophthalmic) is approved for: 1 INDICATIONS AND USAGE ZERVIATE ® (cetirizine ophthalmic solution) 0.24% is indicated for the treatment of ocular itching associated with allergic conjunctivitis. ZERVIATE ® (cetirizine ophthalmic solution) 0.24% is a histamine-1 (H1) receptor antagonist indicated for treatment… For medical advice, please talk to your prescriber or pharmacist.
Zerviate (cetirizine ophthalmic) belongs to the Ophthalmic Antihistamine class of medications.
The FDA label lists Zerviate (cetirizine ophthalmic) as: 3 DOSAGE FORMS AND STRENGTHS Cetirizine ophthalmic solution, 0.24% is a sterile, buffered, clear, colorless aqueous solution containing cetirizine 0.24% (equivalent to cetirizine hydrochloride 0.29%). Ophthalmic solution: 2.4 mg cetirizine in 1 mL sterile solution (0.24%). ( 3 ); ophthalmic route. Available strengths and packaging vary by manufacturer.
Our ingest of the FDA label for Zerviate (cetirizine ophthalmic) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Zerviate (cetirizine ophthalmic) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Zerviate (cetirizine ophthalmic) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA record lists the approval date for Zerviate (cetirizine ophthalmic) as 2017-05-30.
The FDA label lists Harrow Eye, LLC as a labeler/manufacturer of Zerviate (cetirizine ophthalmic). Multiple firms may market generics of the same molecule.
The FDA label states: "Storage: Store at 15°C to 25°C (59°F to 77°F). Single-use containers should be stored in the original foil pouch." Follow the packaging insert for the authoritative guidance.
Loading full data from Know Your Drugs Institute…